Syneron Bio Raises $150 Million in Series B Financing to Enhance Drug Discovery Platform Syneron Bio has successfully completed $150 million in Series B financing to boost its macrocyclic peptide drug development efforts and clinical pipeline enhancements.

Syneron Bio Raises $150 Million in Series B Financing to Enhance Drug Discovery Platform #China #Beijing #Syneron_Bio #Synova #macrocyclic_peptides

Syneron Bio Secures Nearly $100 Million in Series A and A+ Funding Rounds Syneron Bio has successfully raised close to $100 million in Series A and A+ funding, thanks to support from leading global pharmaceutical firms.

Syneron Bio Secures Nearly $100 Million in Series A and A+ Funding Rounds #China #Beijing #AstraZeneca #Syneron_Bio #Synova

Syneron Bio Forms Strategic Partnership with AstraZeneca to Combat Chronic Diseases Syneron Bio has announced a significant partnership with AstraZeneca to utilize its innovative Synova platform, targeting chronic diseases and advancing drug development.

Syneron Bio Forms Strategic Partnership with AstraZeneca to Combat Chronic Diseases #China #Beijing #AstraZeneca #Syneron_Bio #Synova_platform